Tonix Pharmaceuticals Holding Corp (TNXP)

[instock58]

Poor All Needsto Re-Read TNXP / FDA Connection " Tonix is developing Tonmya, which has been conditionally accepted by the U.S. Food and Drug Administration (FDA) as the proposed trade name for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of PTSD. "

" Details of FDA meetings and upcoming milestones in this full report"

https://finance.yahoo.com/news/tonix-pharmaceuticals-prepares-phase-iii-120000887.html


" reakthrough Therapy Type B Clinical Guidance meeting with the U.S. Food and Drug Administration (FDA). The minutes are consistent with the preliminary guidance the Company received at the meeting and confirm FDA’acceptance of the new Phase 3 “RECOVERY” study design."

" *Tonmya has been conditionally accepted by the U.S. Food and Drug Administration (FDA) as the proposed trade name for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of PTSD. TNX-102 SL is an investigational new drug and has not been approved for any indication. "

" Tonix Pharmaceuticals Announces Additional Details of the New Phase 3 Study of Tonmya® for PTSD, Following Receipt of FDA Minutes "


Market / Stock Sentiment BUY - Predictwallstreet
https://www.predictwallstreet.com/PredictNow.aspx?symbol=tnp#


Buy Rated
AmericanBulls.com - Buy Rated

Nasdaq Buy Rating:
https://www.nasdaq.com/symbol/tnxp/analyst-research

https://www.nasdaq.com/symbol/tnxp/stock-consultant


TNXP